EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of Spectrum-Aided Visual Enhancer (SAVE) in Esophageal Cancer Detection Using YOLO Frameworks

Chu-Kuang Chou iD, Riya Karmakar, Yu-Ming Tsao, Lim Wei Jie iD, Arvind Mukundan iD, Chien-Wei Huang, Tsung-Hsien Chen iD, Chau-Yuan Ko, Hsiang-Chen Wang iD

Diagnostics · 29.05.2024 · 14 (11) · 1129

DOI: 10.3390/diagnostics14111129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 29.05.2024. Verfasst von Chu-Kuang Chou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi 60002,…. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Ditmanson Medical Foundation Chia-Yi Christian Hospital and the National Chung Cheng University Joint Research Program, Kaohsiung Armed Forces General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The early detection of esophageal cancer presents a substantial difficulty, which contributes to its status as a primary cause of cancer-related fatalities. This study used You Only Look Once (YOLO) frameworks, specifically YOLOv5 and YOLOv8, to predict and detect early-stage EC by using a dataset sourced from the Division of Gastroenterology and Hepatology, Ditmanson Medical Foundation, Chia-Yi Christian Hospital. The dataset comprised 2741 white-light images (WLI) and 2741 hyperspectral narrowband images (HSI-NBI). They were divided into 60% training, 20% validation, and 20% test sets to facilitate robust detection. The images were produced using a conversion method called the spectrum-aided vision enhancer (SAVE). This algorithm can transform a WLI into an NBI without requiring a spectrometer or spectral head. The main goal was to identify dysplasia and squamous cell carcinoma (SCC). The model’s performance was evaluated using five essential metrics: precision, recall, F1-score, mAP, and the confusion matrix. The experimental results demonstrated that the HSI model exhibited improved learning capabilities for SCC characteristics compared with the original RGB images. Within the YOLO framework, YOLOv5 outperformed YOLOv8, indicating that YOLOv5’s design possessed superior feature-learning skills. The YOLOv5 model, when used in conjunction with HSI-NBI, demonstrated the best performance. It achieved a precision rate of 85.1% (CI95: 83.2–87.0%, p < 0.01) in diagnosing SCC and an F1-score of 52.5% (CI95: 50.1–54.9%, p < 0.01) in detecting dysplasia. The results of these figures were much better than those of YOLOv8. YOLOv8 achieved a precision rate of 81.7% (CI95: 79.6–83.8%, p < 0.01) and an F1-score of 49.4% (CI95: 47.0–51.8%, p < 0.05). The YOLOv5 model with HSI demonstrated greater performance than other models in multiple scenarios. This difference was statistically significant, suggesting that the YOLOv5 model with HSI significantly improved detection capabilities.

Schlagwörter

Stichwörter der Autor:innen

SAVEYOLOv5YOLOv8dysplasiaesophageal cancerhyperspectral imagingnarrowband imagingwhite-light imaging

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi 60002, Taiwan.
  • Obesity Center, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi 60002, Taiwan.
  • Department of Medical Quality, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi 60002, Taiwan.
  • Department of Mechanical Engineering, National Chung Cheng University, Chia-Yi 62102, Taiwan.
  • Department of Computer Science, Multimedia University (Cyberjaya), Persiaran Multimedia, Cyberjaya 63100, Malaysia.
  • Department of Gastroenterology, Kaohsiung Armed Forces General Hospital, 2, Zhongzheng 1st. Rd., Lingya District, Kaohsiung City 80284, Taiwan.

ORCID-Profile: Chu-Kuang Chou, Lim Wei Jie, Arvind Mukundan, Tsung-Hsien Chen, Hsiang-Chen Wang

Förderung

  • National Science and Technology Council
  • Ditmanson Medical Foundation Chia-Yi Christian Hospital and the National Chung Cheng University Joint Research Program
  • Kaohsiung Armed Forces General Hospital
  • National Science and Technology Council, The Republic of China
  • Ditmanson Medical Foundation of Chia-Yi Christian Hospital and the National Chung Cheng University Joint Research Program

Zitieren

APA

Chou, C. K., Karmakar, R., Tsao, Y. M., Jie, L. W., Mukundan, A., Huang, C. W., Chen, T. H., Ko, C. Y., & Wang, H. C. (2024). Evaluation of Spectrum-Aided Visual Enhancer (SAVE) in Esophageal Cancer Detection Using YOLO Frameworks. Diagnostics, 14(11), 1129. https://doi.org/10.3390/diagnostics14111129

Vancouver

Chou CK, Karmakar R, Tsao YM, Jie LW, Mukundan A, Huang CW, et al. Evaluation of Spectrum-Aided Visual Enhancer (SAVE) in Esophageal Cancer Detection Using YOLO Frameworks. Diagnostics. 2024;14(11):1129. doi:10.3390/diagnostics14111129

BibTeX
@article{Chou2024,
  author = {Chou, Chu-Kuang and Karmakar, Riya and Tsao, Yu-Ming and Jie, Lim Wei and Mukundan, Arvind and Huang, Chien-Wei and Chen, Tsung-Hsien and Ko, Chau-Yuan and Wang, Hsiang-Chen},
  title = {Evaluation of Spectrum-Aided Visual Enhancer (SAVE) in Esophageal Cancer Detection Using YOLO Frameworks},
  journal = {Diagnostics},
  year = {2024},
  volume = {14},
  number = {11},
  pages = {1129},
  doi = {10.3390/diagnostics14111129}
}
Kostenlos starten →